#TumorBoardTuesday
🧬Tamoxifen (TAM) helps reduce risk in high risk breast lesions (DCIS, LCIS, ADH, ALH)…what if SEs are intolerable? @drteplinsky @prarthnavb discuss low-dose TAM.
Time for Case Wrap Up! 🎀
🆓#CME: integrityce.com
CME eval🔗: integrityce.com
🧬Tamoxifen (TAM) helps reduce risk in high risk breast lesions (DCIS, LCIS, ADH, ALH)…what if SEs are intolerable? @drteplinsky @prarthnavb discuss low-dose TAM.
Time for Case Wrap Up! 🎀
🆓#CME: integrityce.com
CME eval🔗: integrityce.com
integrityce.com/TBT2023
Tumor Board Tuesday 2023 Conversations
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert fac...
integrityce.com/TBTeval23
Tumor Board Tuesday Evaluation 2023 (ID: i854/i855/i862/i865)
Take this survey powered by surveymonkey.com. Create your own surveys for free.
2/4 #TumorBoardTuesday
Thursday Case🎀
Take🏠:
✅Baby-TAM an option for ADH/ALH/LCIS/DCIS
✅Consider to ⬇️side effects
✅Comparable efficacy to 20mg of tam but ❌ head-to-head comparison
📚Here’s @drteplinsky @prarthnavb’s thread
threadreaderapp.com
Thursday Case🎀
Take🏠:
✅Baby-TAM an option for ADH/ALH/LCIS/DCIS
✅Consider to ⬇️side effects
✅Comparable efficacy to 20mg of tam but ❌ head-to-head comparison
📚Here’s @drteplinsky @prarthnavb’s thread
threadreaderapp.com
3/4 #TumorBoardTuesday
Case🎀
📷 TBT in an image:
Endocrine tx are available for risk reduction, but they come with side effects.
Check out this algo for risk reduction strat in high risk breast lesions, including low dose TAM (5 mg).
Key= patient-centered decision-making
Case🎀
📷 TBT in an image:
Endocrine tx are available for risk reduction, but they come with side effects.
Check out this algo for risk reduction strat in high risk breast lesions, including low dose TAM (5 mg).
Key= patient-centered decision-making
4/4 #TumorBoardTuesday
Case🎀
🙏Any risk reduction strat needs patient centered discussion!
🤔Wider adoption of low dose provide equal benefit w fewer SEs?
📅Brief #ASCO23 break (TBT’s poster abstract #11008). Back in full swing w @MPishvaian’s coveted best of ASCO 06/06/23!
Case🎀
🙏Any risk reduction strat needs patient centered discussion!
🤔Wider adoption of low dose provide equal benefit w fewer SEs?
📅Brief #ASCO23 break (TBT’s poster abstract #11008). Back in full swing w @MPishvaian’s coveted best of ASCO 06/06/23!
Remember #TumorBoardTuesday continues to offer CME credit for FREE! Don’t forget to answer the polls👇🏽
Then click this link to quickly request your credit!
CME eval🔗: integrityce.com
ALL CME 🔗: integrityce.com
Then click this link to quickly request your credit!
CME eval🔗: integrityce.com
ALL CME 🔗: integrityce.com
integrityce.com/TBT2023
Tumor Board Tuesday 2023 Conversations
Tumor Board Tuesdays is a regularly scheduled, Twitter-based case discussion forum led by expert fac...
integrityce.com/TBTeval23
Tumor Board Tuesday Evaluation 2023 (ID: i854/i855/i862/i865)
Take this survey powered by surveymonkey.com. Create your own surveys for free.
Loading suggestions...